Correction to: Eftrenonacog Alfa: A Review in Haemophilia B.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Works matching IS 00126667 AND DT 2023 AND VI 83 AND IP 9
Results: 9
1
2
Rezafungin: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 9, p. 833, doi. 10.1007/s40265-023-01891-8
- By:
- Publication type:
- Article
3
Guideline-Directed Medical Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction.
- Published in:
- Drugs, 2023, v. 83, n. 9, p. 747, doi. 10.1007/s40265-023-01887-4
- By:
- Publication type:
- Article
4
Zavegepant: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 9, p. 825, doi. 10.1007/s40265-023-01885-6
- By:
- Publication type:
- Article
5
Trofinetide: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 9, p. 819, doi. 10.1007/s40265-023-01883-8
- By:
- Publication type:
- Article
6
Nociceptin Receptor-Related Agonists as Safe and Non-addictive Analgesics.
- Published in:
- Drugs, 2023, v. 83, n. 9, p. 771, doi. 10.1007/s40265-023-01878-5
- By:
- Publication type:
- Article
7
Baricitinib for the Treatment of Alopecia Areata.
- Published in:
- Drugs, 2023, v. 83, n. 9, p. 761, doi. 10.1007/s40265-023-01873-w
- By:
- Publication type:
- Article
8
Eftrenonacog Alfa: A Review in Haemophilia B.
- Published in:
- Drugs, 2023, v. 83, n. 9, p. 807, doi. 10.1007/s40265-023-01868-7
- By:
- Publication type:
- Article
9
Results from Expanded Access Programs: A Review of Academic Literature.
- Published in:
- Drugs, 2023, v. 83, n. 9, p. 795, doi. 10.1007/s40265-023-01879-4
- By:
- Publication type:
- Article